Tech Center 1600 • Art Units: 1616 1622 1654 1675
This examiner grants 41% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18609457 | TISSUE FIBROSIS INHIBITOR IN WHICH BIOCOMPATIBLE POLYMER IS USED | Non-Final OA | KM Biologics Co., Ltd. |
| 18426213 | Topical anesthetic agent-clay composite compositions | Non-Final OA | ANDROS PHARMACEUTICALS CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy